Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-09

Clinical Trial Update: Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

View source ↗

Summary

Long-term follow-up results from a trial of transcutaneous auricular neurostimulation aimed at preventing relapse in opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous auricular neurostimulation

Snippet

Sponsor: Spark Biomedical, Inc. | Conditions: Opioid Use Disorder, Relapse | Status: COMPLETED